000 | 01879 a2200481 4500 | ||
---|---|---|---|
005 | 20250516075656.0 | ||
264 | 0 | _c20121009 | |
008 | 201210s 0 0 eng d | ||
022 | _a1476-5381 | ||
024 | 7 |
_a10.1111/j.1476-5381.2012.01892.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMitchell, Callum | |
245 | 0 | 0 |
_aA Ca²⁺-dependent chloride current and Ca²⁺ influx via Ca(v)1.2 ion channels play major roles in P2Y receptor-mediated pulmonary vasoconstriction. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cJun 2012 |
||
300 |
_a1503-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium Channels, L-Type _xmetabolism |
650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
650 | 0 | 4 |
_aChloride Channels _xantagonists & inhibitors |
650 | 0 | 4 |
_aEndothelium, Vascular _xphysiology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 |
_aMembrane Transport Modulators _xpharmacology |
650 | 0 | 4 | _aMyography |
650 | 0 | 4 |
_aPulmonary Artery _xdrug effects |
650 | 0 | 4 |
_aPurinergic Antagonists _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Purinergic P2X1 _xmetabolism |
650 | 0 | 4 |
_aReceptors, Purinergic P2Y _xmetabolism |
650 | 0 | 4 |
_aUridine Diphosphate _xmetabolism |
650 | 0 | 4 |
_aUridine Triphosphate _xmetabolism |
650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
700 | 1 | _aSyed, Nawazish-i-Husain | |
700 | 1 | _aGurney, Alison M | |
700 | 1 | _aKennedy, Charles | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 166 _gno. 4 _gp. 1503-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1476-5381.2012.01892.x _zAvailable from publisher's website |
999 |
_c21531981 _d21531981 |